AZ Kidney Disease & Hyprtnsn Phoenix, AZ - 85012

AZ Kidney Disease & Hyprtnsn is categorized under Doctors in Phoenix, AZ .

AZ Kidney Disease & Hyprtnsn was established in 0, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Doctors business, which does work in the B2C market, and is classified as a Doctors, under code number 6211110 by the NAICS.

If you are seeking more information, feel free to contact Cristi Benetez, Office Manager at the company’s single location by writing to 3003 North Central Avenue # T100, Phoenix, Arizona AZ 85012 or by phoning (602) 263-5446. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: AZ Kidney Disease & Hyprtnsn
Contact Person: Cristi Benetez, Office Manager
Address: 3003 North Central Avenue # T100, Phoenix, Arizona 85012
Phone Number: (602) 263-5446
Website Address: akdhc.net
Annual Revenue (USD): $5.000.000 to $9.999.999
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2C (Business to Consumer)
Business Category: Doctors
SIC Code: 8011
NAICS Code: 6211110
Share This Business:

AZ Kidney Disease & Hyprtnsn was started in 0 to provide professional Doctors under the SIC code 8011 and NAICS code 6211110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.

Feel free to contact Cristi Benetez, Office Manager for inquiries that concern AZ Kidney Disease & Hyprtnsn by calling the company number (602) 263-5446, as your correspondence is most welcome. Additionally, the physical location of the single location of AZ Kidney Disease & Hyprtnsn can be found at the coordinates 33.482477,-112.073627 as well as the street address 3003 North Central Avenue # T100 in Phoenix, Arizona 85012.

For its online presence, you may visit AZ Kidney Disease & Hyprtnsn’s website at akdhc.net and engage with its social media outlets through on Twitter and on Facebook.